Related Experiment Video
Updated: Jul 5, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
Published on: March 6, 2018
Chronic developmental exposure to phenytoin has long-term behavioral consequences
Todd M Mowery1, Angela L McDowell, Preston E Garraghty
1Department of Psychological and Brain Sciences, Indiana University, 1101 E. 10th Street, Bloomington, IN 47405, USA. tmmowery@indiana.edu
Insights
Fetal exposure to phenytoin during gestation and nursing impaired learning and memory in rats. This suggests phenytoin disrupts hippocampal development, impacting adult cognitive function.
Area of Science:
- Neuroscience
- Developmental Toxicology
- Pharmacology
Background:
- Anti-epileptic drugs, like phenytoin, are associated with developmental disorders.
- Fetal exposure to phenytoin can cause Fetal Hydantoin Syndrome in humans.
- Existing animal models do not fully replicate human exposure patterns throughout gestation and nursing.
Purpose of the Study:
- To investigate the long-term effects of chronic phenytoin exposure on learning and memory.
- To explore the relationship between drug exposure during critical developmental periods and cognitive function.
- To utilize a rat model mimicking human gestational and nursing exposure to phenytoin.
Main Methods:
- Rats were exposed to therapeutic levels of phenytoin throughout prenatal development and the pre-weaning period.
- Associative learning was assessed using an appetitive-to-aversive transfer paradigm (hippocampal-dependent).
- Simple and higher-order learning and memory were evaluated using an avoidance-conditioning paradigm.
Main Results:
- Phenytoin-exposed rats showed enhanced acquisition and performance in simple appetitive and avoidance learning tasks.
- A significant impairment in avoidance learning was observed after the transfer from appetitive to aversive conditioning.
- These findings indicate both enhanced simple learning and impaired complex learning in the phenytoin group.
Conclusions:
- Chronic prenatal and early postnatal phenytoin exposure disrupts hippocampal development.
- Impaired hippocampal function in adulthood is suggested by deficits in higher-order learning and memory.
- This study provides insights into the neurodevelopmental consequences of anti-epileptic drug exposure.
Abstract:
Anti-epileptic compounds have been linked to several developmental disorders. Specifically, fetal exposure to phenytoin is linked to fetal hydantoin syndrome in humans. We have developed a rat model of fetal hydantoin syndrome in an effort to explore the relationship between drug exposure, development, and learning and memory. Previous studies of this animal model have used various embryological periods of exposure; however, the human syndrome is reported in the offspring of mothers that maintain drug regimens throughout gestation and nursing. To that end, the present study investigated associative learning in rats exposed to therapeutic levels of phenytoin throughout prenatal development and the postnatal pre-weaning period. We used an instrumental appetitive-to-aversive transfer paradigm, which has hippocampal-dependent components, and an avoidance-conditioning paradigm to test simple associative learning and higher-order learning and memory. Compared to controls, we report increased rates of acquisition and performance by the phenytoin group in both the appetitive and the avoidance learning paradigm, and a substantial impairment in avoidance learning following the transfer from appetitive to aversive conditioning. The positive deficit observed with simple associative learning and the negative transfer effect associated with higher order learning suggests that chronic exposure to phenytoin throughout gestation disrupts hippocampal development, which subsequently leads to impaired function in adulthood.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Drug Toxicity: Dose-Dependent Reactions
Desensitization and Tachyphylaxis
Several...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

